4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-007486
Chief Commercial Officer gave up 1,308 shares (to pay taxes)
- Chief Commercial Officer acquired 3,875 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fair Brett Chief Commercial Officer | 2019-02-01 | Option exercise | +3,875 | 11,890 | D | ||
| Fair Brett Chief Commercial Officer | 2019-02-01 | Shares withheld for taxes | −1,308 | $6.96 | $9,104 | 10,582 | D |
| Derivatives | |||||||
| Fair Brett Chief Commercial Officer | 2019-02-01 | Option exercise · Restricted Stock Units | −3,875 | 11,625 | D | ||
Loading xslF345X03/doc4.xml…